Postoperative pulmonary hypertension: Etiology and treatment of a dangerous complication

Respiratory Care

Volumn 54, Issue 7, 2009, Pages 958-968

  Hill, Nicholas S ^a   Roberts, Kari R ^a   Preston, Ioana R ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Acute right heart syndrome; Heart transplantation; Lung transplantation; Postoperative pulmonary hypertension; Surgery; Thromboendarterectomy

Indexed keywords

ADRENALIN; AMBRISENTAN; AMRINONE; BOSENTAN; CATECHOLAMINE; CYCLIC GMP; DOBUTAMINE; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; GLYCERYL TRINITRATE; HYPERTENSIVE FACTOR; ILOPROST; LEVOSIMENDAN; MILRINONE; NITRIC OXIDE; NORADRENALIN; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN; SILDENAFIL; TADALAFIL; UNIPROST; VASOPRESSIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; CELL PROLIFERATION; CONFERENCE PAPER; DISEASE PREDISPOSITION; DRUG DOSE REDUCTION; ENDARTERECTOMY; FLUID RESUSCITATION; GENETIC PREDISPOSITION; HEART DISEASE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART TRANSPLANTATION; HUMAN; HYPOTENSION; LOW DRUG DOSE; LUNG TRANSPLANTATION; LUNG VASCULAR RESISTANCE; PATHOPHYSIOLOGY; PERFUSION PRESSURE; POSTOPERATIVE COMPLICATION; PULMONARY HYPERTENSION; RISK ASSESSMENT; RISK FACTOR; SURGICAL RISK; SYSTEMIC CIRCULATION; TIDAL VOLUME; VASODILATATION;

EID: 67650496169     PISSN: 00201324     EISSN: None     Source Type: Journal    
DOI: 10.4187/002013209793800439     Document Type: Conference Paper

References (54)

1. Natale ME, Piña IL. Evaluation of pulmonary hypertension in heart transplant candidates. Curr Opin Cardiol 2003;18(2):136-140.
2. Hargett CW, Tapson VF. Classification of pulmonary hypertension. In: Hill NS, Farber HW, editors. Pulmonary Hypertension. New York: Humana; 2008.
3. Viswanathan S, Kumar RK. Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance. Catheter Cardiovasc Interv2008;71(5):665-670.
4. Walls MC, Cimino N, Bolling SF, Bach DS. Persistent pulmonary hypertension after mitral valve surgery: does surgical procedure affect outcome? J Heart Valve Dis 2008;17(1):1-9.
5. Kramm T, Eberle B, Guth S, Mayer E. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardio Thorac Surg 2005;28(6):882-888. (Pubitemid 41735269)
6. Feltracco P, Serra E, Barbieri S, Salvaterra F, Rizzi S, Furnari M, et al. Anesthetic concerns in lung transplantation for severe pulmonary hypertension. Transplant Proc 2007;39(6):1976-1980. (Pubitemid 47198775)
7. Stobierska-Dzierzek B, Awad H, Michler RE. The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 2001;38(4):923-930. (Pubitemid 32912691)
8. Klodell CT, Staples ED, Aranda JM Jr, Schofield RS, Hill JA, Pauly DF, Beaver TM. Managing the post-left ventricular assist device patient. Congest Heart Fail 2006;12(1):41-45.
9. Castro M, Krowka MJ, Schroeder DR, Beck KC, Plevak DJ, Rettke SR, et al. Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clin Proc 1996;7(6)1:543-551. (Pubitemid 126765391)
10. Issa N, Krowka MJ, Griffin MD et al. Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation 2008;86(10):1384-1388.
11. Minai OA, Venkatesah SB, Arroglia AC. Surgical intervention in patients with moderate to severe pulmonary arterial hypertension. Conn Med 2006;70(4):239-243
12. Lai HC, Lai HC, Wang KY, Lee WL, Ting CT, Liu TJ. Severe pulmonary hypertension complicates postoperative outcome of noncardiac. Brit J Anaesth 2007;99(2):184-190. (Pubitemid 47249389)
13. Ramakrishna G, Sprung J, Ravi BS, Chandrasekaran K, McGoon MD. Impact of pulmonary hypertension on the outcomes of noncardiac surgery predictors of perioperative morbidity and mortality. J Am Coll Cardiol 2005;45(10):1691-1699. (Pubitemid 40704508)
14. Farber HW. Pathophysiology of pulmonary hypertension. In: Hill NS, Farber HW, editors. Pulmonary hypertension. New York: Humana; 2008.
15. Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992;327(2):70-75.
16. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med 1995;333(4):214-221.
17. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, et al. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 1993;328(24):1732-1739. (Pubitemid 23170122)
18. Humbert M, Trembath RC. Genetics of pulmonary hypertension: from bench to bedside. Eur Respir J 2002;20(3):741-749. (Pubitemid 35050171)
19. Friesen RH, Williams GD. Anesthetic management of children with pulmonary arterial hypertension. Pediatric Anesthesia 2008;18(3):208-216. (Pubitemid 351159917)
20. McIntyre KM, Sasahara AA. Determinants of right ventricular function and hemodynamics after pulmonary embolism. Chest 1974;65(5):534-543.
21. Bhorade S, Christenson J, O'Connor M, Lavoie A, Pohlman A, Hall JB. Response to inhaled nitric oxide in patients with acute right heart syndrome. Am J Respir Crit Care Med 1999;159(2):571-579. (Pubitemid 29084883)
22. Balzer DT, Kort HW, Day RW, Corneli HM, Kovalchin JP, Cannon BC, et al; The INOP Test Study Group. Inhaled nitric oxide as a preoperative test (INOP test I). Circulation 2002;106(12 Suppl 1):I76-I81.
23. Vieillard-Baron A, Qanadli S, Antakly Y, Fourme T, Loubières Y, Jardin F, Dubourg O. Transesophageal echocardiography for the diagnosis of pulmonary embolism with acute cor pulmonale: a comparison with radiological procedures. Intensive Care Med 1998;24(5):429-433. (Pubitemid 28274153)
24. Murray JF, Karp RB, Nadel JA. Viscosity effects on pressure-flow relations and vascular resistance in dogs' lungs. J Appl Physiol 1969;27:336-341
25. Jardin F, Gueret P, Dubourg O, Farcot JC, Margairez A, Bourdarias JP. Two-dimensional echocardiographic evaluation of right ventricular size and contractility in acute respiratory failure. Crit Care Med 1985;13(11):952-956. (Pubitemid 16229651)
26. Vieillard-Baron A, Schmitt JM, Augarde R, Prin S, Qanadli S, Beauchet A, et al. Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications, and prognosis. Crit Care Med 2001;27(9):1551-1555. (Pubitemid 32762335)
27. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342(18):1301- 1308.
28. Angle MR, Molloy DW, Penner B, Jones D, Prewitt RM. The cardiopulmonary and renal hemodynamic effects of norepinephrine in canine pulmonary embolism. Chest 1989;95(6):1333-1337. (Pubitemid 19160168)
29. Thoren A, Elam M, Ricksten SE. Differential effects of dopamine, dopexamine and dobutamine on jejunal mucosal perfusion early after cardiac surgery. Crit Care Med 2000;28(7):2338-2343. (Pubitemid 30604437)
30. Lobato EB, Gravenstein N, Martin TD. Milrinone, not epinephrine, improves left venticular compliance after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2000;14(4):374-377. (Pubitemid 30629450)
31. Price LC, Forrest P, Sodhi V, Adamson DL. Use of vasopressin after Caesarean section in idiopathic pulmonary arterial hypertension. Brit J Anaesth 2007;99(4):552-555. (Pubitemid 47412500)
32. Gillies M, Bellomo R, Doolan L, Buxton B. Bench-to-bedside review: inotropic drug therapy after adult cardiac surgery - a systematic literature review. Crit Care 2005;9(3):266-279. (Pubitemid 40796804)
33. Jenkins IR, Dolman J, O'Connor JP, Ansley DM. Amrinone versus dobutamine in cardiac surgical patients with severe pulmonary hypertension after cardiopulmonary bypass: aprospective, randomized double-blinded trial. Anaesth Intensive Care 1997;25(3):245-249. (Pubitemid 27296492)
34. Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomized double-blind trial. Lancet 2002;360(9328):196-202. (Pubitemid 34804646)
35. Labriola C, Siro-Brigiani M, Carrata F, Santangelo E, Amantea B. Hemodynamic effects of levosimendan in patients with low output heart failure after cardiac surgery. Int J Clin Pharmacol Ther 2004;42(4):204-211. (Pubitemid 38477436)
36. Morais RJ. Levosimendan in severe right ventricular failure following mitral valve replacement. J Cardiothorac Vasc Anesth 2006;20(1):82-84. (Pubitemid 43182784)
37. Cicekcioglu F, Parlar AI, Ersoy O, Yay K, Hijazi A, Katircioglu SF. Levosimendan and severe pulmonary hypertension during open heart surgery. Gen Thorac Cardiovasc Surg 2008;56(11):563-565
38. Chin KM, Rubin LJ. Pulmonary arterial hypertension. J Am Coll Cardiol 2008;51(16):1527-1538. Erratum in: J AmColl Cardiol 2008;52(2):169.
39. Badesch D, Rubin LJ, McLaughlin V, Simonneau G, Abman S. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007;131(6):1917-1928. (Pubitemid 46981654)
40. Wheller J, George BL, Mulder DG, Jarmakani JM. Diagnosis and management of postoperative pulmonary hypertensive crisis. Circulation 1979;60(7):1640- 1644. (Pubitemid 10207900)
41. Kieler-Jensen N, Milocco I, Ricksten SE. Pulmonary vasodilation after heart transplantation. A comparison among prostacyclin, sodium nitroprusside, and nitroglycerin on right ventricular function and pulmonary selectivity J Heart Lung Transplant 1993;12(2):179-184.
42. De Wet CJ, Affleck DG, Jacobsohn E. Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. J Thorac Cardiovasc Surg 2004;127(4):1058-1067. (Pubitemid 38451939)
43. Kramm T, Eberle B, Guth S, Mayer E. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardio Thorac Surg 2005;28(6):882-888. (Pubitemid 41735269)
44. Rex S, Schaelte G, Metzelder S, Flier S, de Waal EE, Autschbach R, et al. Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial. Acta Anaesthesiol Scand 2008;52(1):65-72.
45. Sütsch G, Bertel O, Kiowski W. Acute and short-term effects of the nonpeptide endothelin-1 receptor antagonist bosentan in humans. Cardiovasc Drugs Ther 1997;10(6):717-725. (Pubitemid 27129775)
46. Bizzarro M, Gross I. Inhaled nitric oxide for the postoperative management of pulmonary hypertension in infants and children with congenital heart disease. Cochrane Database Syst Rev 2005;(4):CD005055.
47. Preston IR, Klinger JR, Houtches J, Nelson D, Farber HW, Hill NS. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension. Respir Med 2005;99(12):1501-1510. (Pubitemid 41683931)
48. De Santo LS, Mastroianni C, Romano G. Role of sildenafil in acute post-transplant right ventricular dysfunction: successful experience in 13 consecutive patients. Transplant Proc 2008;40(6):2015-2018.
49. Klodell CT Jr, Morey TE, Lobato EB, Aranda JM Jr, Staples ED, Schofield RS, et al. Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices. Ann Thorac Surg 2007;83(1):68-71. (Pubitemid 44917910)
50. Vizza CD, Rocca GD, Roma AD, Iacoboni C, Pierconti F, Venuta F, et al. Acute hemodynamic effects of inhaled nitric oxide, dobutamine and a combination of the two in patients with mild to moderate secondary pulmonary hypertension. Crit Care 2001;5(6):355-361. (Pubitemid 34130338)
51. Vater Y, Martay K, Dembo G, Bowdle TA, Weinbroum AA. Intraoperative epoprostenol and nitric oxide for severe pulmonary hypertension during orthotopic liver transplantation: a case report and review of the literature. Med Sci Monit 2006;12(12):CS115-CS118. (Pubitemid 44916063)
52. Flondor M, Merkel M, Hofstetter C, Irlbeck M, Frey L, Zwissler B. The effect of inhaled nitric oxide and inhaled iloprost on hypoxaemia in a patient with pulmonary hypertension after pulmonary thrombarterectomy. Anaesth 2006;61(12):1200-1203. (Pubitemid 44697860)
53. Lee JE, Hillier SC, Knoderer CA. Use of sildenafil to facilitate weaning from inhaled nitric oxide in children with pulmonary hypertension following surgery for congenital heart disease. J Intensive Care Med 2008;23(5):329-334.
54. Klinger JR, Thaker S, Houtchens J, preston IR, Hill NS, Farber HW. Pulmonary hemodynamic responses to brain natriuretic peptide an sildenafil in patients with pulmonary arterial hypertension. Chest 2006;129(2):417-425.